Valuation: Celltrion, Inc.

Market Cap 46,095B 32.54B 28.12B 26.46B 24.06B 45.13B 3,105B 45.91B 310B 121B 1,556B 122B 120B 5,198B P/E 2026 *
30.6x
P/E 2027 * 26.4x
Enterprise Value 48.07B 33.94M 29.32M 27.59M 25.09M 47.06M 3.24B 47.88M 323M 126M 1.62B 127M 125M 5.42B EV / Sales 2026 *
8.82x
EV / Sales 2027 * 7.49x
Free-Float
58.26%
Yield 2026 *
0.38%
Yield 2027 * 0.41%
1 day-0.50%
1 week+0.85%
Current month+7.66%
1 month+14.40%
3 months+11.78%
6 months-11.32%
Current year+16.60%
1 week 194,850
Extreme 194850
212,000
1 month 168,200
Extreme 168200
212,000
Current year 158,500
Extreme 158500
239,047.62
1 year 158,500
Extreme 158500
239,047.62
3 years 114,250.83
Extreme 114250.828535
239,047.62
5 years 114,250.83
Extreme 114250.828535
247,058.06
10 years 64,487.59
Extreme 64487.593381
325,235.48
Manager TitleAgeSince
Chief Executive Officer 65 20/03/2015
Chief Executive Officer 42 26/03/2021
President 50 13/02/2026
Director TitleAgeSince
Chairman 68 -
Director/Board Member 61 01/04/2005
Director/Board Member 66 -
Date Insider Type Main position Quantity % Market Cap.
1/16/26 A Sell 500 0.0002%
1/16/26 A Sell 1,000 0.0004%
1/16/26 A Sell 1,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-0.50%+0.85%+20.60%+49.65% 32.61B
-1.78%-1.68%+1.48%+15.31% 48.42B
+0.85%-0.70%+460.88%+563.55% 43.66B
-2.40%-0.23%+8.13%+71.41% 39.51B
-2.01%-0.85%+23.85%+8.73% 38.95B
+0.38%-3.23% - - 16.32B
-0.59%-2.06%+26.35%+118.09% 16.15B
+0.49%+0.92%+4.11%+23.67% 14.16B
-0.43%+4.70%+78.74%+33.31% 13.37B
-2.59%-0.83%-7.22%-37.03% 12.59B
Average -0.86%+0.36%+68.55%+94.08% 27.57B
Weighted average by Cap. -0.99%+0.53%+90.83%+124.70%

Financials

2026 *2027 *
Net sales 5,449B 3.85B 3.32B 3.13B 2.84B 5.33B 367B 5.43B 36.63B 14.31B 184B 14.44B 14.13B 615B 6,325B 4.47B 3.86B 3.63B 3.3B 6.19B 426B 6.3B 42.51B 16.62B 214B 16.76B 16.4B 713B
Net income 1,485B 1.05B 906M 853M 775M 1.45B 100B 1.48B 9.98B 3.9B 50.15B 3.94B 3.85B 168B 1,768B 1.25B 1.08B 1.01B 923M 1.73B 119B 1.76B 11.89B 4.65B 59.71B 4.69B 4.58B 199B
Net Debt 1,978B 1.4B 1.21B 1.14B 1.03B 1.94B 133B 1.97B 13.29B 5.2B 66.78B 5.24B 5.13B 223B 1,262B 891M 770M 725M 659M 1.24B 85.04B 1.26B 8.49B 3.32B 42.63B 3.35B 3.27B 142B
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,680
Date Price Change Volume
14/08/26 ₩201,000.00 -0.50% 341,446
13/08/26 ₩202,000.00 0.00% 679,170
12/08/26 ₩202,000.00 -4.04% 926,438
11/08/26 ₩210,500.00 +4.73% 886,325
10/08/26 ₩201,000.00 +0.85% 533,999
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
201,000.00KRW
Average target price
264,708.89KRW
Spread / Average Target
+31.70%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A068270 Stock